BioLargo, Inc.
BLGO
$0.2639
-$0.0002-0.08%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -13.22% | 5.34% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -13.22% | 5.34% | |||
| Cost of Revenue | -8.62% | 14.44% | |||
| Gross Profit | -19.42% | -4.85% | |||
| SG&A Expenses | -12.94% | 8.04% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -8.33% | 6.90% | |||
| Operating Income | -19.21% | -16.64% | |||
| Income Before Tax | -35.90% | -0.65% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -35.90% | -0.65% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 54.28% | -7.12% | |||
| Net Income | -21.77% | -7.56% | |||
| EBIT | -19.21% | -16.64% | |||
| EBITDA | -19.20% | -17.47% | |||
| EPS Basic | -20.00% | -7.14% | |||
| Normalized Basic EPS | 28.57% | -75.00% | |||
| EPS Diluted | -20.00% | -7.14% | |||
| Normalized Diluted EPS | 28.57% | -75.00% | |||
| Average Basic Shares Outstanding | 1.37% | 0.72% | |||
| Average Diluted Shares Outstanding | 1.37% | 0.72% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
